Plasmodium falciparum plasma membrane (PPM)

The Plasmodium falciparum plasma membrane (PPM) is a complex and dynamic lipid bilayer that serves as the primary interface between the malaria parasite and its host erythrocyte environment. It is essential for maintaining the parasite's internal physiological conditions, facilitating the uptake of host-derived nutrients, and exporting metabolic waste products such as lactic acid. The PPM houses critical transport proteins, including the P-type Na+-ATPase (PfATP4), which maintains low cytosolic sodium levels, and the Chloroquine Resistance Transporter (PfCRT), which mediates drug efflux. Because the parasite relies heavily on these membrane-bound processes for survival and osmotic stability, the PPM and its associated proteins are major targets for antimalarial chemotherapy. Drugs like Cipargamin target specific membrane ion pumps to induce rapid parasite swelling and death, while others disrupt the unique phospholipid metabolism required for membrane expansion during the parasite's rapid replication. However, the 'Malaria parasite membrane' is considered a broad structural entity rather than a single molecular target, as it encompasses a vast array of proteins and lipid species with distinct functions.

Other names

Malaria parasite membraneParasite plasma membraneP. falciparum plasma membraneErythrocytic stage parasite membrane

Inhibition of membrane-bound ion-motive ATPases (e.g., PfATP4), disruption of lipid bilayer integrity, interference with phospholipid biosynthesis, and inhibition of nutrient/drug transporters (e.g., PfCRT, PfENT1).